27 May 2022 in Science Advances
Candida albicans is a widespread commensal fungus with substantial pathogenic potential and steadily increasing resistance to current antifungal drugs. It is known to be resistant to cycloheximide (CHX) that binds to the E–transfer RNA binding site of the ribosome. Because of lack of structural information, it is neither possible to understand the nature of the resistance nor to develop novel inhibitors. To overcome this issue, we determined the structure of the vacant C. albicans 80 S ribosome at 2.3 angstroms and its complexes with bound inhibitors at resolutions better than 2.9 angstroms using cryo–electron microscopy. Our structures reveal how a change in a conserved amino acid in ribosomal protein eL42 explains CHX resistance in C. albicans and forms a basis for further antifungal drug development.
1 October 2014 in Applied Magnetic Resonance
24 April 2025 in Proceedings of the National Academy of Sciences
Nonsense mutations are associated with numerous and diverse pathologies, yet effective treatment strategies remain elusive. A promising approach to combat these conditions involves the use of aminoglycosides, particularly in combination with stop-codon read-through enhancers, for developing drugs that can rescue the production of full-length proteins. Using X-ray crystallography and single-particle cryo-EM, we obtained structures of the eukaryotic ribosome in complexes with several aminoglycosides (geneticin G418, paromomycin, and hygromycin B) and the antimalarial drug mefloquine (MFQ), which has also been identified as a read-through enhancer. Our study reveals a binding site of MFQ, which holds significant promise for the development of therapies targeting premature termination codon-related genetic and oncological diseases. The results underscore the crucial role of the bridge B7b/c in mediating the effects of MFQ on subunit rotation dynamics. Through a comprehensive analysis of the interactions between the drugs and the eukaryotic ribosome, we propose a unifying hypothesis for read-through enhancement by small molecules, highlighting the role of decoding center rearrangements and intersubunit rotation dynamics.
4 January 2025 in bioRxiv
The assembly of the mitoribosomal small subunit involves folding and modification of rRNA, and its association with mitoribosomal proteins. This process is assisted by a dynamic network of assembly factors. Conserved methyltransferases Mettl15 and Mettl17 act on the solvent-exposed surface of rRNA. Binding of Mettl17 is associated with the early assembly stage, whereas Mettl15 is involved in the late stage, but the mechanism of transition between the two was unclear. Here, we integrate structural data from Trypanosoma brucei with mammalian homologs and molecular dynamics simulations. We reveal how the interplay of Mettl15 and Mettl17 in intermediate steps links the distinct stages of small subunit assembly. The analysis suggests a model wherein Mettl17 acts as a platform for Mettl15 recruitment. Subsequent release of Mettl17 allows a conformational change of Mettl15 for substrate recognition. Upon methylation, Mettl15 adopts a loosely bound state which ultimately leads to its replacement by initiation factors, concluding the assembly. Together, our results indicate that assembly factors Mettl15 and Mettl17 cooperate to regulate the biogenesis process, and present a structural data resource for understanding molecular adaptations of assembly factors in mitoribosome.
3 July 2026 in Nucleic Acids Research
Cellular chromatin is the first non-reversible contact point between incoming infectious agents, such as integrating viruses, and their host genomes. Retroviral integration depends on interactions between the viral intasome and host chromatin, involving interfaces between integrase, target DNA, and nucleosomal histones. While factors like LEDGF/p75 and chromatin compaction influence these interactions, the molecular mechanisms regulating access to nucleosomal interfaces remain unclear. In this study, we dissected how incoming intasomes engage nucleosome surfaces to facilitate integration. Using biochemical assays and molecular docking, we demonstrated that HIV-1 and PFV intasomes specifically bind distinct nucleosomal surfaces. Mapping these interactions onto trinucleosomes and simulating dynamic docking revealed that neighboring nucleosomes can mask functional interfaces, modulating HIV-1’s ability to access its target. Conversely, PFV intasomes are less affected by chromatin compaction due to persistent accessibility of active nucleosomal sites. These findings provide the first structural insights into how chromatin architecture influences retroviral integration. Our results highlight divergent strategies by HIV-1 and PFV to engage chromatin, revealing how nucleosome properties govern the formation of active strand transfer complexes and emphasizing the evolution of virus-specific adaptation to chromatin landscapes.